• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

43
14
13
11
11

COUNTRY

7
5
4
3
3

CATEGORIES

  • 50
  • 23
  • 18
  • 11
  • 9
  • 8
  • 7
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

44
49
62
148

PUBLISHED

0
10
53
148

PRODUCT TYPE

105
43

Search "AstraZeneca: Performance, Products, Pipeline and Potential" returned 148 results.

PRODUCT TITLE

AstraZeneca PLC (AZN) - Financial and Strategic SWOT Analysis Review

AstraZeneca PLC (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

April 2014
FROM

Diabetes - KOL Insight and Consensus Outlook Modules

The medium term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth Rising levels of obesity and disease prevalence in both established...

September 2013
FROM
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis Lung Cancer Therapeutics Market Outlook and Pipeline Analysis - Product Thumbnail Image

Lung Cancer Therapeutics Market Outlook and Pipeline Analysis

With over 50% of all non-small cell lung cancer (NSCLC) patients diagnosed at the advanced stages of the disease, and 95% of all small-cell lung cancer (SCLC) patients unsuitable for surgical resection,...

November 2009
FROM
Global Biopharma Outlook 2012 - Major US and EU Pharma Global Biopharma Outlook 2012 - Major US and EU Pharma - Product Thumbnail Image

Global Biopharma Outlook 2012 - Major US and EU Pharma

Global Biopharma Outlook 2012 –Major US and EU Pharma Unarguably 2011 was one of the very good years for the global Pharma industry as the USFDA approved a trend setting 39 new drugs, which is way ahead...

January 2012
FROM
DPP IV Inhibitors - Global Strategic Business Report DPP IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP IV Inhibitors - Global Strategic Business Report

This report analyzes the worldwide markets for DPP-IV Inhibitors in US$ Million by the following drugs – Sitagliptin, Vildagliptin, Saxagliptin, and Other DPP-IV Inhibitors (including Linagliptin and...

September 2011
FROM

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

The global COPD market is estimated to currently be worth $11 3 billion, and is forecast to reach a value of $15 6 billion by 2019 Much of this growth will be fuelled by a high number of new, more efficacious...

June 2013
FROM
Global Biopharma Outlook 2011: Major US and EU Global Biopharma Outlook 2011: Major US and EU - Product Thumbnail Image

Global Biopharma Outlook 2011: Major US and EU

The year 2011 and 2012 will be a bonanza for generic companies, as large innovator companies will lose patent exclusivity on prescription drugs worth over $70b in sales It is imperative to understand...

February 2011
FROM

Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity

Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries Being overweight or obese is a major risk factor in...

August 2013
FROM
Astra Tech AB - Strategic SWOT Analysis Review Astra Tech AB - Strategic SWOT Analysis Review - Product Thumbnail Image

Astra Tech AB - Strategic SWOT Analysis Review

Astra Tech AB - Strategic SWOT Analysis Review Summary Astra Tech AB (Astra Tech) is a medical device company engaged in the research, development, manufacture and marketing of dental implants and...

August 2011
FROM
Small Molecule Kinase Inhibitors - Global Strategic Business Report Small Molecule Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Kinase Inhibitors - Global Strategic Business Report

This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb,...

July 2009
FROM
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights - Product Thumbnail Image

The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights

Pain continues to present numerous challenges to the biopharmaceutical industry According to the American Academy of Pain Medicine, over 76 million Americans suffer from pain Indeed, pain affects more...

October 2010
FROM

Diabetes: Battle for Ascendancy Escalates in Expanding Market – KOL Insight

Diabetes is one of the few disease areas that has retained its market value despite the entry of generics, the rise in drug prices and prevalence of the disease has allowed drug sales to soar to a worldwide...

August 2013
FROM

Healthcare, Regulatory and Reimbursement Landscape - Portugal

Healthcare, Regulatory and Reimbursement Landscape - Portugal Summary GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape...

March 2013
FROM

Fc Protein and Glycoengineered Antibodies Market, 2013 - 2023

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies Developed through introduction of modifications in monoclonal...

September 2013
FROM
Personalized Medicine 2010 Personalized Medicine 2010 - Product Thumbnail Image

Personalized Medicine 2010

Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies The era of Personalized Medicine is set to revolutionize the healthcare industry As our knowledge...

May 2010
FROM

Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Depression Therapeutics - Pipeline Assessment...

October 2011
FROM

KOL Insight: Prostate Cancer: Competition Intensifies in Race to the Top

The Prostate Cancer market has seen a number of progressive changes in recent years The launches of Johnson & Johnson's Zytiga (abiraterone acetate) and Medivation/Astellas's Xtandi (enzalutamide) has...

June 2013
FROM

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

August 2012
FROM

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market...

November 2012
FROM

Brodalumab (Psoriasis) - Forecast and Market Analysis to 2022

Brodalumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2–3% worldwide...

May 2013
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.